source
- ‘Selling and marketing snake oil’: The debate over compounded GLP-1sProponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH confer…BioPharma Dive · 42m ago↗ source
- Novo’s consumer push gains momentum with Wegovy pill, CagriSema on deckLAS VEGAS — When Ed Cinca returned to Novo after four years away, he barely recognized the place. “I think the building’s the same, but that’s about it,” Cinca, Novo’s senior vice president of mark…Endpoints · 1h ago↗ source
- White House pulls nomination for FDA nominee OvertonThe sudden end of Heidi Overton’s candidacy likely ensures a Democrat-controlled Congress will choose the FDA’s next leader — but shouldn’t disrupt the agency, analysts say.